ADAPTIVE BIOTECHNOLOGIES COR shareholders Q2 2023

ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 209 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q2 2023. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.

ADAPTIVE BIOTECHNOLOGIES COR shareholders Q2 2023
NameSharesValueWeighting ↓
Blue Water Life Science Advisors, LP 3,030,434$20,334,21213.72%
BERYLSON CAPITAL PARTNERS, LLC 228,000$1,529,8804.32%
Eagle Health Investments LP 1,214,860$8,151,7111.52%
Matrix Capital Management Company, LP 11,572,590$77,652,0790.90%
Triatomic Management LP 121,166$813,0240.83%
VIKING GLOBAL INVESTORS LP 29,993,708$201,257,7810.82%
Aristotle Atlantic Partners, LLC 3,104,961$20,834,2880.78%
Pier Capital, LLC 737,589$4,949,2220.71%
ARK Investment Management 10,453,752$70,144,6750.46%
Nikko Asset Management Americas, Inc. 6,384,047$42,773,1150.45%
Olympiad Research LP 31,699$212,7000.21%
Leeward Financial Partners, LLC 54,097$362,9910.21%
ESSEX INVESTMENT MANAGEMENT CO LLC 211,706$1,420,5470.20%
Rappaport Reiches Capital Management, LLC 68,080$456,8170.19%
Bouvel Investment Partners, LLC 43,823$294,0490.16%
Senator Investment Group LP 500,000$3,355,0000.15%
BRAIDWELL LP 648,451$4,351,1060.14%
PURA VIDA INVESTMENTS, LLC 155,059$1,040,4460.14%
Edge Wealth Management LLC 90,000$603,9000.13%
PIER 88 INVESTMENT PARTNERS LLC 71,625$480,6040.12%
External links

This page lists ADAPTIVE BIOTECHNOLOGIES COR's shareholders in Q2 2023. To view ADAPTIVE BIOTECHNOLOGIES COR's shareholder history, click here.